Anji Pharmaceuticals
Improving Lives Globally
Role of the Gut in the Glucose-lowering Effects of Metformin
Capstone Therapeutics Announces Results of Special Shareholder Meeting, and a License Transfer/Royalty Agreement and Exit from the Pharmaceutical Development Business
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes Read Now
